Suchergebnisse - "Schulze, Lisa Lou"

PubPharm (8)

1

Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2023

von Schulze, L. | Becker, E. | Dedden, M. | +18

2

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells

enthalten in: Gut | 2023

von Ullrich, K. | Derdau, J. | Baltes, C. | +25

3

Controlling in and out - the future of interfering with immune cell trafficking in inflammatory bowel disease

enthalten in: Expert review of clinical immunology | 2023

von Zundler, S. | Schulze, L. | Neurath, M.

4

Preclinical Analysis of the Mechanisms and Efficacy of Ontamalimab (anti-MAdCAM-1) in Inflammatory Bowel Disease

Erschienen: Dissertation, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2022

von Schulze, L. | Zundler, S. | Engelkamp, D.

5

Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19

enthalten in: Frontiers in immunology | 2021

von Müller, T. | Becker, E. | Wiendl, M. | +6

6

Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing

enthalten in: Gut | 2020

von Schleier, L. | Wiendl, M. | Heidbreder, K. | +16

CommentIn: Gut. 2020 Jul;69(7):1359-1361. - PMID 31201286

7

Immunology of IL-12 : An update on functional activities and implications for disease

enthalten in: EXCLI journal | 2020

von Ullrich, K. | Schulze, L. | Paap, E. | +3

8

Immune cell trafficking and retention in inflammatory bowel disease : mechanistic insights and therapeutic advances

enthalten in: Gut | 2019

von Zundler, S. | Becker, E. | Schulze, L. | +1

1
[1]